OTCMKTS:EAPIF Euroapi (EAPIF) Stock Price, News & Analysis C$0.84 0.00 (0.00%) As of 10/15/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartNews and Trends About Euroapi Stock (OTCMKTS:EAPIF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Euroapi alerts:Sign Up Key Stats Today's RangeC$0.84▼C$0.8450-Day RangeC$0.84▼C$1.1752-Week RangeC$0.84▼C$3.59VolumeN/AAverage Volume1,575 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview EUROAPI is a France-based pharmaceutical company that develops, manufactures and markets active pharmaceutical ingredients (APIs), the substances responsible for the therapeutic effects of medicines. The company supplies APIs for use in a range of prescription and over-the-counter medicines, serving pharmaceutical companies and other healthcare customers. Its portfolio includes chemical and biological APIs, as well as specialized products such as peptides and complex molecules. EUROAPI also provides contract development and manufacturing services, supporting customers from process development and scale-up through commercial production and regulatory supply. EUROAPI was established in 2022 through the separation and listing of Sanofi’s API business. The company operates an international manufacturing and research network with sites in France, Germany, Italy, Hungary and the United Kingdom, serving customers in European and other global pharmaceutical markets.AI Generated. May Contain Errors. Read More Receive EAPIF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Euroapi and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EAPIF Stock News HeadlinesMedisca and EUROAPI Form Strategic Partnership to Strengthen API Access for Pharmaceutical CompoundingOctober 7, 2026 | businesswire.comEuroapi S.A. (EAPIF) Q2 2026 Earnings Call TranscriptJuly 30, 2026 | seekingalpha.com“The crisis that’s emerging now is just the tip of the iceberg,” says Dr. Martin D. Weiss, who has made shocking and accurate predictions for 55 yearsDr. Martin D. Weiss, who predicted the Dot-Com collapse and the failures of Fannie Mae, Bear Stearns, and Lehman Brothers, is warning of a developing financial crisis. The New York Times has credited him as among the first to see the dangers ahead, and Forbes dubbed him Mr. Independence. He says this emerging situation could trigger a chain reaction across banks and markets. Watch his free video breakdown and see the five steps he outlines for investors.October 16 at 1:00 AM | Weiss Ratings (Ad)EUROAPI statement regarding the Brindisi siteMay 13, 2026 | globenewswire.comEUROAPI - Availability of the 2025 Universal Registration DocumentMarch 27, 2026 | globenewswire.comEuroapi S.A. (EAPIF) Q4 2025 Earnings Call TranscriptMarch 4, 2026 | seekingalpha.comWith Med4Cure, EUROAPI accelerates pharmaceutical innovation at the service of health sovereigntyOctober 23, 2025 | globenewswire.comScience Based Targets initiative (SBTi) validates EUROAPI's near-term climate targetsSeptember 18, 2025 | globenewswire.comSee More Headlines EAPIF Stock Analysis - Frequently Asked Questions How have EAPIF shares performed this year? Euroapi's stock was trading at C$2.63 on January 1st, 2026. Since then, EAPIF shares have decreased by 67.9% and is now trading at C$0.84. How do I buy shares of Euroapi? Shares of EAPIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:EAPIF CIKN/A Webwww.euroapi.com Phone33 1 89 20 62 00FaxN/AEmployees3,133Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (OTCMKTS:EAPIF) was last updated on 10/15/2026 by MarketBeat.com Staff. From Our PartnersElon Musk’s 4th Wealth Window Set to Open by October 30Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He po...Brownstone Research | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredSpaceX minted 4400 millionaires in a single daySpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...Behind the Markets | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredThe oil check Munger called his best dealCharlie Munger's $1,000 oil investment in 1962 later paid about $70,000 a year, totaling roughly $1 million ov...The Oxford Club | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Euroapi S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Euroapi With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.